J Knee Surg 2015; 28(05): 411-416
DOI: 10.1055/s-0035-1549023
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Effect of Comorbidities on Outcomes following Total Knee Arthroplasty

Randa D. K. Elmallah
1   Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, Baltimore, Maryland
,
Jeffrey J. Cherian
1   Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, Baltimore, Maryland
,
Kristin Robinson
2   Clinical Research Department, Stryker Orthopaedics, Mahwah, New Jersey
,
Steven F. Harwin
3   Department of Orthopaedic Surgery, Beth Israel Medical Center, New York, New York
,
Michael A. Mont
1   Rubin Institute for Advanced Orthopedics, Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, Baltimore, Maryland
› Author Affiliations
Further Information

Publication History

03 December 2014

02 January 2015

Publication Date:
18 April 2015 (online)

Abstract

To enhance the success of total knee arthroplasty (TKA), clinicians must identify factors that may impede functional recovery. Multiple comorbidities may affect outcomes, and our purpose was to identify the role of overall disease burden, as well as individual comorbidities, on post-TKA outcomes. We prospectively reviewed 283 TKA patients (172 women, 111 men). Preexisting comorbidities were weighted using the Charlson comorbidity index (CCI). Patients were divided into four groups: CCI score of 0 to 1, 2, 3, or 4 or more and followed up at 6 weeks, 3 months, 1 year, and annually until 5 years. The most prevalent comorbidities were also individually assessed at these follow-ups. The effect of these on outcomes was evaluated using the Knee Society Score (KSS), Short Form 36 (SF-36), and lower extremity activity scale (LEAS). Patients who had lower CCI scores had significant improvements in KSS at 2- and 5-year follow-up (+34 and +38 points, respectively; p < 0.01). CCI scores of 0 to l demonstrated significantly greater improvement in the SF-36 physical component score (PCS) at final follow-up (+16 points; p < 0.05) and higher LEAS scores at 2 years postoperatively (p = 0.001), compared with the remaining cohorts. Endocrine disease and hypertension yielded significantly lower KSS at follow-up (−5 and −5 points, respectively; p < 0.05). Patients who had hypertension or gastrointestinal disease had significantly lower SF-36 PCS at final follow-up compared with those who did not (45 vs. 48 points and 47 vs. 49 points; p < 0.035 and 0.041, respectively), as well as lower activity scores (11 vs. 12 points for both comorbidities; p < 0.05). Patients who had cardiovascular disease had significantly lower SF-36 MCS (53 vs. 56 points, respectively; p = 0.03) at 4 years postoperatively than those without, as well as lower activity scores (11 vs. 12 points, respectively; p = 0.024). Patients who have lower CCIs may have improved activity and functional levels following TKA. Hypertension, cardiovascular disease, endocrine disease, and gastrointestinal disease may correlate with poorer functional and activity outcomes postoperatively.

 
  • References

  • 1 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (4) 780-785
  • 2 Gelber AC, Hochberg MC, Mead LA, Wang NY, Wigley FM, Klag MJ. Body mass index in young men and the risk of subsequent knee and hip osteoarthritis. Am J Med 1999; 107 (6) 542-548
  • 3 Apold H, Meyer HE, Nordsletten L, Furnes O, Baste V, Flugsrud GB. Weight gain and the risk of knee replacement due to primary osteoarthritis: a population based, prospective cohort study of 225,908 individuals. Osteoarthritis Cartilage 2014; 22 (5) 652-658
  • 4 Miric A, Inacio MC, Kelly MP, Namba RS. Can total knee arthroplasty be safely performed among nonagenarians? An evaluation of morbidity and mortality within a total joint replacement registry. J Arthroplasty 2014; 29 (8) 1635-1638
  • 5 Singh JA, O'Byrne M, Harmsen S, Lewallen D. Predictors of moderate-severe functional limitation after primary Total Knee Arthroplasty (TKA): 4701 TKAs at 2-years and 2935 TKAs at 5-years. Osteoarthritis Cartilage 2010; 18 (4) 515-521
  • 6 Kapadia BH, Issa K, Nagrare N, Pivec R, Banerjee S, Mont MA. Higher revision and complication rates following total hip arthroplasty in patients with inflammatory bowel disease. J Arthroplasty 2014; 29 (3) 596-600
  • 7 Singh JA, Lewallen DG. Depression in primary TKA and higher medical comorbidities in revision TKA are associated with suboptimal subjective improvement in knee function. BMC Musculoskelet Disord 2014; 15: 127
  • 8 Singh JA, Lewallen DG. Diabetes: a risk factor for poor functional outcome after total knee arthroplasty. PLoS ONE 2013; 8 (11) e78991
  • 9 Inneh IA, Lewis CG, Schutzer SF. Focused risk analysis: regression model based on 5,314 total hip and knee arthroplasty patients from a single institution. J Arthroplasty 2014; 29 (10) 2031-2035
  • 10 Clement ND, MacDonald D, Burnett R, Breusch SJ. Diabetes does not influence the early outcome of total knee replacement: a prospective study assessing the Oxford knee score, short form 12, and patient satisfaction. Knee 2013; 20 (6) 437-441
  • 11 Kuo FC, Hsu CH, Chen WS, Wang JW. Total knee arthroplasty in carefully selected patients aged 80 years or older. J Orthop Surg 2014; 9: 61
  • 12 Nilssen Y, Strand TE, Wiik R , et al. Utilizing national patient-register data to control for comorbidity in prognostic studies. Clin Epidemiol 2014; 6: 395-404
  • 13 Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 1989; (248) 13-14
  • 14 Patel AA, Donegan D, Albert T. The 36-item short form. J Am Acad Orthop Surg 2007; 15 (2) 126-134
  • 15 Saleh KJ, Mulhall KJ, Bershadsky B , et al. Development and validation of a lower-extremity activity scale. Use for patients treated with revision total knee arthroplasty. J Bone Joint Surg Am 2005; 87 (9) 1985-1994
  • 16 Wylde V, Dieppe P, Hewlett S, Learmonth ID. Total knee replacement: is it really an effective procedure for all?. Knee 2007; 14 (6) 417-423
  • 17 Lizaur-Utrilla A, Gonzalez-Parreño S, Miralles-Muñoz FA, Lopez-Prats FA, Gil-Guillen V. Patient-related predictors of treatment failure after primary total knee arthroplasty for osteoarthritis. J Arthroplasty 2014; 29 (11) 2095-2099
  • 18 Desmeules F, Dionne CE, Belzile EL, Bourbonnais R, Champagne F, Frémont P. Determinants of pain, functional limitations and health-related quality of life six months after total knee arthroplasty: results from a prospective cohort study. BMC Sports Sci Med Rehabil 2013; 5: 2
  • 19 Ghomrawi HM, Kane RL, Eberly LE, Bershadsky B, Saleh KJ ; North American Knee Arthroplasty Revision (NAKAR) Study Group. Patterns of functional improvement after revision knee arthroplasty. J Bone Joint Surg Am 2009; 91 (12) 2838-2845
  • 20 Singh JA. Effect of comorbidity on quality of life of male veterans with prevalent primary total knee arthroplasty. Clin Rheumatol 2009; 28 (9) 1083-1089
  • 21 Ayers DC, Li W, Oatis C, Rosal MC, Franklin PD. Patient-reported outcomes after total knee replacement vary on the basis of preoperative coexisting disease in the lumbar spine and other nonoperatively treated joints: the need for a musculoskeletal comorbidity index. J Bone Joint Surg Am 2013; 95 (20) 1833-1837
  • 22 Issa K, Jauregui JJ, Given K, Harwin SF, Mont MAA. A prospective, longitudinal study of patient activity levels following total knee arthroplasty stratified by demographic and comorbid factors. J Knee Surg 2014; [Epub ahead of print]. PMID: 25162408